Deepwise Medical Showcases New AI-Powered Solutions at 2019 China Medical Equipment Exhibition

VCBeat (WeChat ID: vcbeat) has learned that the China Medical Equipment Conference and the 2019 Medical Equipment Exhibition were grandly held in Suzhou from July 18 to 21, 2019. Themed “Gathering Wisdom for Safe Application and Industrial Innovation, Jointly Planning the Future Development of Medical Equipment,” the conference invited more than 30,000 industry elites, including government officials, academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, renowned experts, and hospital presidents. Qiao Xin, Co-founder and CEO of DeepWise, attended the ribbon-cutting ceremony at the opening ceremony of the conference.

Ribbon-Cutting Ceremony at the Conference Opening (Second from Left: Qiao Xin, Co-Founder/CEO of DeepWise)

As an innovative enterprise in medical artificial intelligence, DeepWise was invited to attend this grand event, showcasing its full range of AI products and solutions, including the Dr.Wise® AI-Assisted Diagnostic System, Dr.Wise® Cloud Intelligent Imaging Cloud, and Dr.Wise® Radimics Multimodal Research Platform. Multiple innovative AI products became the focal point of the venue.

At the Artificial Intelligence Conference, Mr. Xin Guobin, Vice Minister of Industry and Information Technology, stated in his speech: “Deepening the integrated development of medical equipment and artificial intelligence in China is a major task for advancing the construction of a manufacturing powerhouse and a Healthy China. In the next step, we must fully leverage the advantages of China’s vast medical data resources and its enormous market application scale, accelerate the transformation of scientific and technological achievements, and actively cultivate AI-based products and services.” In his report, he also repeatedly mentioned DeepWise, a rapidly growing company that has collaborated with numerous top-tier medical institutions in China to achieve multiple outcomes. After the conference, accompanied by leaders of the Chinese Association of Medical Equipment, Minister Xin visited the DeepWise exhibition booth.

Minister of Industry and Information Technology Xin Guobin Visits DeepWise Booth

“Aim High, Stay Grounded” was the expectation Vice Minister Xin Guobin set for the entire industry at last year’s Artificial Intelligence Forum. Upholding this spirit, DeepWise has forged ahead with continuous progress and a steadfast commitment to innovation over the past year.

During his report to Minister Xin, Qiao Xin, Co-founder and CEO of DeepWise, pointed out that at last year’s exhibition, DeepWise’s Dr.Wise® AI-assisted medical diagnostic system comprised only two products. After a year of research and development investment, the Dr.Wise® AI-assisted medical diagnostic system now offers six products, which can be widely applied in early screening for lung cancer and breast cancer, assessment of children’s growth and development, assisted diagnosis of stroke, screening for thoracic diseases, and detection of complex joint lesions.

DeepWise Co-Founder and CEO Qiao Xin Introduces New AI Products to Vice Minister of Industry and Information Technology Xin Guobin

At this exhibition, DeepWise’s newly launched Dr. Wise^®AI-Assisted Diagnostic System for Complex Joint X-rays is applicable to various clinical scenarios, including radiology departments and emergency trauma surgery. It can detect and mark complex, minute fracture lesions in five areas: hand joints, wrist joints, foot joints, ankle joints, and elbow joints. Simultaneously, it classifies the detected lesions (e.g., fractures, foreign bodies, postoperative changes). The system enables rapid detection, providing immediate lesion localization for interpreting physicians. With advantages such as high sensitivity and high specificity, the system achieves a detection rate of 97%, ensuring no minute lesions are missed. It demonstrates excellent performance in detecting conditions prone to missed diagnosis, particularly occult fractures, avulsion fractures, and dislocations. The system exhibits strong diagnostic robustness and is compatible with X-ray equipment of various brands and models.

In an interview with the conference’s news center, Qiao Xin, Co-founder and CEO of DeepWise, stated, “DeepWise has continuously innovated, establishing a comprehensive portfolio of AI-powered healthcare products, including AI-assisted diagnostic systems for medical imaging, intelligent cloud-based imaging platforms, multimodal research platforms, in-hospital intelligent consultation and triage systems, and AI-driven pathological testing systems. Recently, DeepWise completed its Series C financing round, raising hundreds of millions of RMB. This achievement reflects industry recognition of the company’s growth since its founding over two years ago. Looking ahead, DeepWise will continue to advance the intelligence of healthcare products around the concept of ‘Smart Healthcare,’ driven by business innovation, to accelerate hospitals’ digital transformation, empower their smart future, and serve more medical institutions.”

Li Chaoyang, Senior Vice President of DeepWise, delivered a keynote address at the conference, highlighting DeepWise’s commitment to continuous innovation and leveraging AI to facilitate efficient medical decision-making. Looking ahead, DeepWise will expand its AI initiatives and explorations across the broader health sector, building a forward-looking artificial intelligence ecosystem. The company’s products and services will evolve from single-disease diagnosis and treatment to comprehensive multi-disease care, from standalone technology applications to an integrated technological ecosystem, and from unimodal data learning to multimodal human-computer interaction. Together with industry peers, DeepWise aims to promote the development of new technologies and the application of new scenarios in China’s artificial intelligence field.

Li Chaoyang, Senior Vice President of DeepWise

At the conference, Li Yiming, Co-founder and CTO of DeepWise, delivered a speech titled “Exploration of AI Applications in the Healthcare Sector.” He pointed out, “Currently, AI+Healthcare has gradually integrated artificial intelligence technologies into fields such as medical imaging, assisted diagnosis and treatment, virtual assistants, health management, and drug discovery. AI-enabled healthcare is ubiquitous, spanning from diagnosis to assistance, and from analysis to research; AI is becoming increasingly embedded in our daily lives. Nevertheless, current applications of AI+Healthcare represent only the tip of the iceberg. It holds immense potential, and we believe that human wisdom will ultimately unveil its mysteries layer by layer in the future.”

Li Yiming, Co-founder/CTO of DeepWise

Chen Er, Director of the Marketing and Product Department at DeepWise, delivered a keynote address titled “AI Empowering Primary Care to Facilitate Tiered Diagnosis and Treatment.” She pointed out that as a country with a large population, China faces a shortage of medical and health resources, uneven distribution of these resources, and significant disparities in medical service levels between urban and rural areas. How to integrate medical resources through artificial intelligence and internet technologies to help physicians address clinical challenges has become an urgent issue for smart healthcare to resolve.

DeepWise Dr.Wise^®Cloud Intelligent Imaging Cloud consists of three functional components: Cloud PACS, Cloud AI, and Cloud Film. The platform is an online medical imaging diagnostic center based on application virtualization technology, integrated with DeepWise’s artificial intelligence-assisted diagnostic technology, enabling physicians to access medical imaging data and AI processing results quickly and efficiently anytime, anywhere. The platform provides professional and user-friendly multi-terminal tools for online image review and remote diagnostic reporting, delivers precise AI-based recommendations, and facilitates vertical collaboration between tertiary hospitals and primary care institutions within the region as well as interoperability of medical data. It establishes an efficient and convenient online connection among specialists, hospitals, and patients, and can be widely applied in scenarios such as tiered diagnosis and treatment, two-way referral, expert consultation, and remote research and education. With Cloud Film, patients can scan the QR code on their reports via mobile devices to view textual and graphical report results and browse DICOM images, meeting the needs of various imaging diagnostic scenarios.

Chen Er, Director of Market Products at DeepWise

Liang Lei, Product Manager at DeepWise, presented the company’s product development history and its robust scientific research capabilities at the conference.

Liang Lei, Product Manager at DeepWise

DeepWise’s product portfolio integrates cloud computing, big data, and artificial intelligence. The company is emerging as the most comprehensive enterprise in the medical AI sector, both in breadth and depth. By leveraging the complementary advantages of its diverse products, DeepWise continuously upgrades and iterates product performance while developing new offerings. This approach fully supports the development of smart healthcare and the implementation of tiered diagnosis and treatment, benefiting a broader population and making access to medical care easier.